Lorenzini et al. demonstrated that REAC treatment improved locomotion in aged mice carrying the human amyloid precursor protein mutation (model for Alzheimer's disease) (29). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.